Gluteneze

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

Amylase, Quantity: 10 thousand DU; cellulase, Quantity: 4 thousand CU; protease, Quantity: 31.25 Thousand HUT; lipase, Quantity: 40 LipU

Disponibbli minn:

Miasca Investments Pty Ltd

Għamla farmaċewtika:

Capsule, hard

Kompożizzjoni:

Excipient Ingredients: medium chain triglycerides; microcrystalline cellulose; hypromellose; purified water

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Decrease/reduce/relieve colic (wind/gas pain) ; Decrease/reduce/relieve excess intestinal gas ; Maintain/support healthy digestive system function ; Maintain/support healthy digestion ; Maintain/support digestion/assimilation of nutrients ; Aid/assist digestion/breakdown of dietary fat ; Aid/assist/helps digestion of fats/fatty acids/triglycerides/lipid ; Aid/assist digestion of glucose/sugar/carbohydrates ; Helps reduce occurrence of symptoms of medically diagnosed gluten sensitivity caused by inadvertent gluten ingestion ; Maintain/support digestive system health ; Decrease/reduce/relieve abdominal bloating/distention ; Decrease/reduce/relieve abdominal cramping ; Decrease/reduce/relieve abdominal feeling of fullness ; Relieve digestive discomfort ; Helps reduce occurrence of symptoms of food intolerance

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Listed

Data ta 'l-awtorizzazzjoni:

2020-12-15